S
Surgical Science Sweden AB
STO:SUS
Surgical Science Sweden AB
STO:SUS
Price:
126
SEK
-2.25%
Market Closed
Market Cap:
6.4B
SEK
Income Statement
Earnings Waterfall
Surgical Science Sweden AB
Surgical Science Sweden AB
|
Revenue
|
884.1m
SEK
|
|
Cost of Revenue
|
-286.2m
SEK
|
|
Gross Profit
|
597.9m
SEK
|
|
Operating Expenses
|
-453.6m
SEK
|
|
Operating Income
|
144.3m
SEK
|
|
Other Expenses
|
-12.7m
SEK
|
|
Net Income
|
131.6m
SEK
|
Income Statement
Surgical Science Sweden AB
Surgical Science Sweden AB
Currency: SEK
Millions
TTM
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||
| Revenue |
52
N/A
|
53
+1%
|
54
+3%
|
60
+10%
|
57
-4%
|
58
+0%
|
60
+5%
|
64
+6%
|
66
+3%
|
68
+4%
|
70
+2%
|
88
+27%
|
102
+15%
|
107
+6%
|
112
+4%
|
104
-7%
|
105
+0%
|
122
+17%
|
138
+13%
|
209
+51%
|
367
+76%
|
489
+33%
|
640
+31%
|
750
+17%
|
803
+7%
|
872
+9%
|
901
+3%
|
906
+1%
|
883
-3%
|
842
-5%
|
838
0%
|
860
+3%
|
884
+3%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||
| Cost of Revenue |
6
|
6
|
6
|
5
|
4
|
(1)
|
(6)
|
(10)
|
(17)
|
(17)
|
(17)
|
(18)
|
(18)
|
(18)
|
(17)
|
(16)
|
(16)
|
(19)
|
(22)
|
(45)
|
(101)
|
(151)
|
(207)
|
(249)
|
(271)
|
(285)
|
(293)
|
(291)
|
(270)
|
(265)
|
(264)
|
(270)
|
(286)
|
|
| Gross Profit |
58
N/A
|
59
+1%
|
60
+2%
|
65
+8%
|
61
-5%
|
57
-8%
|
55
-4%
|
54
-2%
|
49
-8%
|
52
+5%
|
53
+2%
|
70
+34%
|
84
+19%
|
90
+7%
|
95
+6%
|
89
-7%
|
88
0%
|
103
+17%
|
117
+13%
|
164
+41%
|
266
+62%
|
338
+27%
|
433
+28%
|
502
+16%
|
532
+6%
|
587
+11%
|
607
+3%
|
615
+1%
|
613
0%
|
578
-6%
|
574
-1%
|
590
+3%
|
598
+1%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||
| Operating Expenses |
(58)
|
(59)
|
(60)
|
(64)
|
(66)
|
(65)
|
(62)
|
(59)
|
(53)
|
(56)
|
(57)
|
(64)
|
(68)
|
(70)
|
(73)
|
(69)
|
(68)
|
(80)
|
(92)
|
(139)
|
(209)
|
(263)
|
(323)
|
(356)
|
(369)
|
(392)
|
(402)
|
(402)
|
(424)
|
(416)
|
(427)
|
(447)
|
(454)
|
|
| Selling, General & Administrative |
(21)
|
(22)
|
(23)
|
(23)
|
(25)
|
(28)
|
(31)
|
(35)
|
(39)
|
(43)
|
(43)
|
(49)
|
(51)
|
(52)
|
(54)
|
(51)
|
(41)
|
(59)
|
(66)
|
(104)
|
(123)
|
(169)
|
(198)
|
(201)
|
(168)
|
(221)
|
(228)
|
(236)
|
(204)
|
(233)
|
(239)
|
(233)
|
(214)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(4)
|
(7)
|
(10)
|
(14)
|
(13)
|
(13)
|
(15)
|
(17)
|
(19)
|
(19)
|
(18)
|
(10)
|
(16)
|
(21)
|
(33)
|
(56)
|
(97)
|
(130)
|
(159)
|
(157)
|
(179)
|
(185)
|
(182)
|
(164)
|
(181)
|
(181)
|
(186)
|
(176)
|
|
| Depreciation & Amortization |
(9)
|
(9)
|
(10)
|
(11)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(33)
|
0
|
0
|
0
|
(50)
|
0
|
0
|
0
|
(54)
|
0
|
0
|
(14)
|
(59)
|
|
| Other Operating Expenses |
(29)
|
(27)
|
(27)
|
(30)
|
(31)
|
(34)
|
(24)
|
(14)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
(1)
|
(1)
|
(5)
|
(5)
|
(3)
|
2
|
2
|
5
|
4
|
6
|
8
|
11
|
15
|
(2)
|
(2)
|
(6)
|
(14)
|
(5)
|
|
| Operating Income |
(0)
N/A
|
0
N/A
|
0
-81%
|
1
+1 143%
|
(4)
N/A
|
(8)
-102%
|
(8)
+7%
|
(5)
+31%
|
(4)
+25%
|
(4)
-8%
|
(4)
+2%
|
6
N/A
|
15
+145%
|
19
+28%
|
22
+13%
|
20
-10%
|
20
+1%
|
23
+15%
|
24
+6%
|
25
+1%
|
57
+129%
|
74
+31%
|
111
+49%
|
146
+32%
|
163
+11%
|
196
+20%
|
205
+5%
|
213
+4%
|
189
-11%
|
162
-14%
|
148
-9%
|
143
-3%
|
144
+1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(0)
|
(5)
|
(2)
|
(7)
|
32
|
11
|
0
|
(4)
|
65
|
50
|
53
|
64
|
79
|
79
|
89
|
97
|
28
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(14)
|
|
| Pre-Tax Income |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
1
N/A
|
(4)
N/A
|
(9)
-96%
|
(8)
+9%
|
(5)
+31%
|
(4)
+25%
|
(4)
-4%
|
(4)
+3%
|
7
N/A
|
15
+130%
|
20
+31%
|
22
+9%
|
19
-12%
|
20
+2%
|
18
-9%
|
22
+24%
|
18
-20%
|
66
+269%
|
86
+30%
|
111
+29%
|
142
+28%
|
208
+47%
|
245
+18%
|
258
+5%
|
277
+7%
|
268
-3%
|
241
-10%
|
237
-2%
|
237
+0%
|
158
-33%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||
| Tax Provision |
4
|
4
|
4
|
4
|
2
|
2
|
2
|
2
|
(0)
|
(1)
|
(1)
|
(0)
|
(3)
|
(3)
|
(3)
|
(5)
|
(4)
|
(0)
|
(1)
|
12
|
20
|
16
|
13
|
(3)
|
(20)
|
(24)
|
(24)
|
(24)
|
(34)
|
(33)
|
(39)
|
(44)
|
(26)
|
|
| Income from Continuing Operations |
3
|
4
|
3
|
4
|
(3)
|
(7)
|
(6)
|
(4)
|
(5)
|
(5)
|
(5)
|
6
|
13
|
17
|
19
|
14
|
16
|
18
|
21
|
30
|
86
|
101
|
124
|
138
|
188
|
221
|
234
|
253
|
234
|
208
|
198
|
193
|
132
|
|
| Net Income (Common) |
3
N/A
|
4
+15%
|
3
-8%
|
4
+23%
|
(3)
N/A
|
(7)
-159%
|
(6)
+11%
|
(4)
+41%
|
(5)
-29%
|
(5)
-8%
|
(5)
0%
|
6
N/A
|
13
+101%
|
17
+35%
|
19
+9%
|
14
-23%
|
16
+9%
|
18
+14%
|
21
+21%
|
30
+39%
|
86
+188%
|
101
+17%
|
124
+23%
|
138
+11%
|
188
+36%
|
221
+18%
|
234
+6%
|
253
+8%
|
234
-7%
|
208
-11%
|
198
-5%
|
193
-2%
|
132
-32%
|
|
| EPS (Diluted) |
0.23
N/A
|
1.31
+470%
|
1.21
-8%
|
0.87
-28%
|
-0.13
N/A
|
-1.37
-954%
|
-1.22
+11%
|
-0.72
+41%
|
-0.19
+74%
|
-0.18
+5%
|
-0.2
-11%
|
0.19
N/A
|
0.43
+126%
|
0.5
+16%
|
0.53
+6%
|
0.41
-23%
|
0.45
+10%
|
0.47
+4%
|
0.56
+19%
|
0.75
+34%
|
2.02
+169%
|
1.98
-2%
|
2.43
+23%
|
2.71
+12%
|
3.69
+36%
|
4.35
+18%
|
4.59
+6%
|
4.96
+8%
|
4.59
-7%
|
4.08
-11%
|
3.87
-5%
|
3.79
-2%
|
2.58
-32%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
